- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2009-015981-73.
Displaying page 1 of 1.
EudraCT Number: 2009-015981-73 | Sponsor Protocol Number: GERICO 09/0907 | Start Date*: 2009-12-08 | ||||||||||||||||
Sponsor Name:FNCLCC (Fédération Nationale des Centres de Lutte Contre le Cancer) | ||||||||||||||||||
Full Title: Phase II study evaluating the toxicity and activity of the combination lapatinib + capecitabine in elderly patients aged 70 and over with metastatic breast cancer over expressing HER2 | ||||||||||||||||||
Medical condition: Locally advanced or metastatic breast cancer over expressing HER2 and ≥ 70 years old | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Ongoing) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
